Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) Sees Significant Increase in Short Interest
Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Rating) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 113,000 shares, a growth of 32.0% from the March 15th total of 85,600 shares. Currently, 1.2% of the company’s shares are sold short. Based […]
Minot Wealth Management Aridis Pharmaceuticals Get Rating Aridis Pharmaceuticals Virtu Financial Zacks Investment Research Aridis Pharmaceuticals Inc
Source: etfdailynews.com